These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27295307)

  • 21. Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy.
    Molhoek SG; Bax JJ; van Erven L; Bootsma M; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    Am J Cardiol; 2004 Apr; 93(7):860-3. PubMed ID: 15050489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Right atrial size and deformation in patients with dilated cardiomyopathy undergoing cardiac resynchronization therapy.
    D'Andrea A; Scarafile R; Riegler L; Salerno G; Gravino R; Cocchia R; Castaldo F; Allocca F; Limongelli G; Di Salvo G; Cuomo S; Pacileo G; Caso P; Russo MG; Calabrò R
    Eur J Heart Fail; 2009 Dec; 11(12):1169-77. PubMed ID: 19926601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Equilibrium radionuclide angiography compared with tissue doppler imaging for detection of right ventricular dyssynchrony and prediction of acute response to cardiac resynchronization therapy.
    Chen Y; Xue X; Gu Y; Xu H; Zhang X
    Medicine (Baltimore); 2020 Feb; 99(9):e19296. PubMed ID: 32118744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy.
    Valzania C; Fallani F; Gavaruzzi G; Biffi M; Martignani C; Diemberger I; Bertini M; Domenichini G; Ziacchi M; Gadler F; Eriksson MJ; Braunschweig F; Franchi R; Branzi A; Rapezzi C; Boriani G
    Am J Cardiol; 2010 Aug; 106(3):389-94. PubMed ID: 20643252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of mechanical dyssynchrony in cardiac resynchronization therapy.
    Risum N
    Dan Med J; 2014 Dec; 61(12):B4981. PubMed ID: 25441737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of myocardial viability on responsiveness to cardiac resynchronization in ischemic dilated cardiomyopathy: a prospective observational cohort study.
    Pugliese M; Minardi G; Vitali A; Natale E; De Girolamo P; Zampi G; Leggio M; Chiarelli A; Pappalardo A; Avella A; Laurenzi F; Fera MS
    Anadolu Kardiyol Derg; 2012 Mar; 12(2):132-41. PubMed ID: 22281793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of left ventricular size on response to cardiac resynchronization therapy.
    Rickard J; Brennan DM; Martin DO; Hsich E; Tang WH; Lindsay BD; Starling RC; Wilkoff BL; Grimm RA
    Am Heart J; 2011 Oct; 162(4):646-53. PubMed ID: 21982656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Right and left ventricular dysfunction in patients with dilated cardiomyopathy: a study with equilibrium radionuclide ventriculography.
    Araki H; Caglar N; Hisano R; Nagata Y; Ogata I; Fukuyama T; Nakamura M
    J Cardiogr; 1985 Mar; 15(1):155-61. PubMed ID: 4067341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incremental value of right ventricular indices for predicting response to cardiac resynchronization therapy.
    Szulik M; Streb W; Lenarczyk R; Stabryła-Deska J; Kowalski O; Kalarus Z; Kukulski T
    J Am Soc Echocardiogr; 2011 Feb; 24(2):170-179.e3. PubMed ID: 21177070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
    Sundell J; Engblom E; Koistinen J; Ylitalo A; Naum A; Stolen KQ; Kalliokoski R; Nekolla SG; Airaksinen KE; Bax JJ; Knuuti J
    J Am Coll Cardiol; 2004 Mar; 43(6):1027-33. PubMed ID: 15028362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, dyssynchrony, and contractile function in patients with New York Heart Association functional class I/II heart failure: MADIT-CRT.
    Knappe D; Pouleur AC; Shah AM; Bourgoun M; Brown MW; Foster E; Pfeffer MA; Moss AJ; Solomon SD;
    J Card Fail; 2013 Mar; 19(3):149-55. PubMed ID: 23482074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony.
    Carluccio E; Biagioli P; Alunni G; Murrone A; Pantano P; Biscottini E; Zuchi C; Zingarini G; Cavallini C; Ambrosio G
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1067-76. PubMed ID: 21999865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implication of right ventricular to left ventricular interlead sensed electrical delay in cardiac resynchronization therapy.
    Kristiansen HM; Hovstad T; Vollan G; Keilegavlen H; Faerestrand S
    Europace; 2012 Jul; 14(7):986-93. PubMed ID: 22308084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy.
    Fernández-Armenta J; Berruezo A; Mont L; Sitges M; Andreu D; Silva E; Ortiz-Pérez JT; Tolosana JM; de Caralt TM; Perea RJ; Calvo N; Trucco E; Borràs R; Matas M; Brugada J
    Europace; 2012 Nov; 14(11):1578-86. PubMed ID: 22562658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of intraventricular mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy: comparison between tissue Doppler imaging and real-time three-dimensional echocardiography.
    Kleijn SA; van Dijk J; de Cock CC; Allaart CP; van Rossum AC; Kamp O
    J Am Soc Echocardiogr; 2009 Sep; 22(9):1047-54. PubMed ID: 19647409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perfusion and metabolic scintigraphy with (123)I-BMIPP in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy.
    Zavadovsky KV; Gulya MO; Lishmanov YB; Lebedev DI
    Ann Nucl Med; 2016 Jun; 30(5):325-33. PubMed ID: 26872805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of equilibrium radionuclide angiography to predict acute response to cardiac resynchronization therapy in patients with heart failure.
    Chen Y; Yan J; Zhao S; Long Q; Wang H; Wang L
    Nucl Med Commun; 2015 Jun; 36(6):610-8. PubMed ID: 25759945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The impact of cardiac resynchronization therapy on left ventricular diastolic function evaluated by speckle tracking imaging in patients with dilated cardiomyopathy].
    Lu J; Dai M; Qian DJ; Zhang CY; Cao LJ; Wang RX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Nov; 41(11):940-4. PubMed ID: 24370222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of cardiac resynchronization therapy in patients with advanced congestive heart failure evaluated by real-time 3-dimensional echocardiography].
    Zhao YH; Zhang JY; Wei CH; Wang XQ; Zhang J; Xu Y; Gao CY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Aug; 41(8):668-73. PubMed ID: 24225238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.